Edwards Lifesciences (EW) PT Raised to $125 at Cowen Following Intraquarter Checks

July 23, 2021 6:26 AM EDT
Get Alerts EW Hot Sheet
Price: $119.42 -1.05%

Rating Summary:
    22 Buy, 15 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 3 | New: 9
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Cowen analyst Joshua Jennings raised the price target on Edwards Lifesciences (NYSE: EW) to $125.00 (from $100.00) while maintaining a Outperform rating following intraquarter checks.

The analyst commented, "Intraquarter checks have increased our confidence in the TAVR market’s recovery pace and driven our view that EW’s 2Q set up is highly favorable. Positive investor sentiment has increased in stride with 2Q expectations. We believe EW will deliver a 2Q beat and positively revise guidance, which should be good enough to sustain recent momentum in EW shares. Reiterate Outperform. PT moves to $125."



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Cowen & Co